Morgan Stanley Backs Tenaya Therapeutics (TNYA) as SMID-Cap Biotech Primed to Outperform in 2026

2 weeks ago 10

Maham Fatima

Mon, January 19, 2026 astatine 7:01 AM CST 2 min read

Tenaya Therapeutics Inc. (NASDAQ:TNYA) is 1 of the overlooked maturation stocks to buy. On January 8, Morgan Stanley lowered the firm’s terms people connected Tenaya Therapeutics to $2 from $5 and kept an Overweight standing connected the shares. In a assemblage outlook note, the steadfast predicted that the US small-to-mid headdress biotech stocks volition proceed to outperform successful 2026. This bullish presumption is driven by commercial-stage companies transitioning from superior consumers to producers and a looming patent cliff that is presently threatening the gross of large-cap biopharma.

Earlier connected December 16, Canaccord Genuity precocious lowered its terms people for Tenaya Therapeutics to $4 from $6, portion maintaining a Buy rating. This accommodation reflected the interaction of a caller $60 cardinal superior rise (completed successful December 2025), which caused immoderate shareholder dilution but extended the company’s currency runway into mid-2027.

Morgan Stanley Backs Tenaya Therapeutics (TNYA) arsenic SMID-Cap Biotech Primed to Outperform successful 2026

On December 12, H.C. Wainwright besides lowered its terms people for Tenaya Therapeutics Inc. (NASDAQ:TNYA) to $3 from $5 portion maintaining a Buy rating. This simplification was besides chiefly owed to the stock dilution resulting from the company’s $60 cardinal nationalist offering. This superior raise, priced astatine $1.20 per unit, was indispensable for extending Tenaya’s currency runway done mid-2027, arsenic mentioned previously, and besides for supporting its cardinal cistron therapy programs.

Tenaya Therapeutics Inc. (NASDAQ:TNYA) is simply a clinical-stage biotech institution that discovers, develops, and delivers therapies for bosom illness successful the US.

While we admit the imaginable of TNYA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.